feed,title,long_url,short_url
ğŸ”MarketWatch,Adicet Bio shares fall as it shares clinical data about its CAR-T treatment candidate,http://www.marketwatch.com/news/story/adicet-bio-shares-fall-shares/story.aspx?guid=%7BD83FA5EC%2D75CA%2D43EC%2DA04E%2DFF02CE03DED0%7D&siteid=rss,https://da.gd/6C6W
ğŸ”MarketWatch,Playtika to lay off 15% of its staff,http://www.marketwatch.com/news/story/playtika-lay-off-15-its/story.aspx?guid=%7B2893DCDF%2DB843%2D4A93%2DBCE4%2D78CD243F04B9%7D&siteid=rss,https://da.gd/XKlNl
ğŸ”MarketWatch,Chimera Investment shares rise on new CEO and co-chief investment officers,http://www.marketwatch.com/news/story/chimera-investment-shares-rise-new/story.aspx?guid=%7B62D9F210%2DB115%2D4D1E%2DB710%2D705BDCAE2716%7D&siteid=rss,https://da.gd/1nHJ
ğŸ”MarketWatch,MariMed searches for new CEO after death of Robert Fireman,http://www.marketwatch.com/news/story/marimed-searches-new-ceo-after/story.aspx?guid=%7B33EADB01%2D615F%2D4FFD%2DB953%2D18221CB7687D%7D&siteid=rss,https://da.gd/hEGVE8
ğŸ”MarketWatch,Under Armour stock gains after Stifel upgrade,http://www.marketwatch.com/news/story/under-armour-stock-gains-after/story.aspx?guid=%7B187CA422%2D53D8%2D4CD5%2D8788%2DB31996A1494A%7D&siteid=rss,https://da.gd/Ys1U
ğŸ”MarketWatch,Aptevo's stock rallies 107% after sharing preliminary data about experimental leukemia treatment,http://www.marketwatch.com/news/story/aptevos-stock-rallies-107-after/story.aspx?guid=%7B8A3BBA52%2DBADB%2D478D%2DB592%2DB2588D8DA641%7D&siteid=rss,https://da.gd/NutC
ğŸ”MarketWatch,Kellogg board approves share buyback program of up to $1.5 billion,http://www.marketwatch.com/news/story/kellogg-board-approves-share-buyback/story.aspx?guid=%7B2575FF73%2DC7F0%2D4ECD%2D8C66%2D9248E7375B6F%7D&siteid=rss,https://da.gd/tiWHES
ğŸ”MarketWatch,Nasdaq adds six companies to the Nasdaq-100 Index,http://www.marketwatch.com/news/story/nasdaq-adds-six-companies-nasdaq-100/story.aspx?guid=%7BD5E56F58%2D935D%2D4205%2DB7E7%2D1EAD9FE39F9E%7D&siteid=rss,https://da.gd/UTn75l
